Arnold & Porter

Arnold & Porter advises life sciences clients on regulatory, transactional, IP, public policy, and litigation matters affecting the sector. The firm handles matters involving emerging scientific fields, including immuno-oncology, cell and gene therapy, and novel diagnostics. Daniel Kracov chairs the global life sciences practice and advises clients on FDA regulatory strategy, compliance, enforcement issues, clinical research matters, and government and internal investigations relating to product and compliance issues. Jeffrey Handwerker advises on pharmaceutical pricing and contracting, as well as coverage, reimbursement, and investigations and litigation affecting life sciences and healthcare companies. Mahnu Davar focuses on regulatory and compliance matters involving pharmaceutical, biologics, and medical device products, and co-chairs the firm's life sciences and healthcare regulatory team with Allison Shuren. Kristin Hicks advises on compliance issues including anti-kickback matters involving specialty pharmacy arrangements, PBM and GPO relationships, wholesaler agreements, and patient assistance programs. Abeba Habtemariam advises pharmaceutical and medical device manufacturers on regulatory, compliance, and legislative matters. All lawyers mentioned above are based in Washington, DC.